[Autism and Autism-associated Metabolites]

Area of Science:

• Neuroscience
• Microbiology
• Genetics

Background:

• Gene-microbiota interactions are increasingly viewed as a form of gene-environmental interaction.
• The gut microbiome's role in health and disease is a rapidly expanding area of research.

Purpose of the Study:

• To explore the potential role of a specific serum metabolite and its association with gut microbiome alterations in the pathogenesis of autism.
• To investigate how this metabolite may influence neurodevelopmental processes and gene expression.

Main Methods:

• Review of preclinical and clinical data.
• Analysis of the association between serum metabolite levels and gut microbiome composition.
• Examination of potential epigenetic mechanisms and gene expression modulation in neural cells.

Main Results:

• A specific serum metabolite, altered in conjunction with gut microbiome changes, shows potential involvement in autism onset.
• This metabolite may induce epigenetic perturbations, affecting the expression of autism-susceptible genes during neurodevelopment.
• The gut microbiota is recognized as a source of environmental epigenetic factors.

Conclusions:

• Gene-microbiota interactions and specific metabolites represent a novel pathway in autism pathogenesis.
• Epigenetic modifications mediated by metabolites and the microbiome may be critical during neurodevelopmental windows.
• Further research into these interactions could reveal new therapeutic targets for autism spectrum disorder.